BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25752319)

  • 21. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body composition and metabolic factors in obese children and adolescents.
    Tershakovec AM; Kuppler KM; Zemel BS; Katz L; Weinzimer S; Harty MP; Stallings VA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):19-24. PubMed ID: 12532149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of insulin resistance with cardiovascular risk factors and inflammatory cytokines in normal-weight Hispanic women.
    Vella CA; Burgos X; Ellis CJ; Zubia RY; Ontiveros D; Reyes H; Lozano C
    Diabetes Care; 2013 May; 36(5):1377-83. PubMed ID: 23275356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism.
    van Nimwegen LJ; Storosum JG; Blumer RM; Allick G; Venema HW; de Haan L; Becker H; van Amelsvoort T; Ackermans MT; Fliers E; Serlie MJ; Sauerwein HP
    J Clin Endocrinol Metab; 2008 Feb; 93(2):572-7. PubMed ID: 18029467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women.
    Aasen G; Fagertun H; Halse J
    Scand J Clin Lab Invest; 2008; 68(3):204-11. PubMed ID: 18446527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
    Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
    Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics.
    Weber M; Wyne K
    Schizophr Res; 2006 Mar; 83(1):95-101. PubMed ID: 16507343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
    Murashita M; Inoue T; Kusumi I; Nakagawa S; Itoh K; Tanaka T; Izumi T; Hosoda H; Kangawa K; Koyama T
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):54-8. PubMed ID: 17239039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort.
    Mousa A; Naderpoor N; de Courten MPJ; Scragg R; de Courten B
    J Steroid Biochem Mol Biol; 2017 Oct; 173():258-264. PubMed ID: 28007531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary microvascular function, insulin sensitivity and body composition in predicting exercise capacity in overweight patients with coronary artery disease.
    Jürs A; Pedersen LR; Olsen RH; Snoer M; Chabanova E; Haugaard SB; Prescott E
    BMC Cardiovasc Disord; 2015 Nov; 15():159. PubMed ID: 26613591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic medications: metabolic and cardiovascular risk.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps.
    Zhang B; Deng L; Wu H; Lu X; Peng L; Wu R; Guo W; Chen J; Li L; Zhao J
    Schizophr Res; 2016 Oct; 176(2-3):259-263. PubMed ID: 27377977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of obesity indices, metabolic parameters and age on cardiac autonomic function in abdominally obese men.
    Poliakova N; Després JP; Bergeron J; Alméras N; Tremblay A; Poirier P
    Metabolism; 2012 Sep; 61(9):1270-9. PubMed ID: 22444779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Glucoregulation in normal weight schizophrenia patients treated by first generation antipsychotics].
    Marić N; Doknić M; Damjanović A; Pekić S; Jasović-Gasić M; Popović V
    Srp Arh Celok Lek; 2008; 136(3-4):110-5. PubMed ID: 18720742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
    Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between nocturnal blood pressure dipping and insulin metabolism in obese adolescents.
    Westerståhl M; Marcus C
    Int J Obes (Lond); 2010 Mar; 34(3):472-7. PubMed ID: 19752880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women.
    Peppa M; Koliaki C; Papaefstathiou A; Garoflos E; Katsilambros N; Raptis SA; Hadjidakis DI; Dimitriadis GD
    Obesity (Silver Spring); 2013 Sep; 21(9):1807-14. PubMed ID: 23696298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
    Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
    J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.